Literature DB >> 2751288

Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.

J E Mortensen1, A Brumbach, T R Shryock.   

Abstract

Two veterinary pathogens, Bordetella bronchiseptica and Bordetella avium, were tested for their antimicrobial susceptibilities. Of the 20 antimicrobial agents tested, both species were consistently resistant to penicillin and cefuroxime but susceptible to mezlocillin, piperacillin, gentamicin, amikacin, and cefoperazone.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2751288      PMCID： PMC172531          DOI： 10.1128/AAC.33.5.771

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 2.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

3.  Bordetella bronchiseptica pneumonia in a patient with chronic lymphocytic leukemia.

Authors:  B P Buggy; F C Brosius; R M Bogin; C A Koller; D R Schaberg
Journal:  South Med J       Date:  1987-09       Impact factor: 0.954

4.  Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.

Authors:  D A Strandberg; J H Jorgensen; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

6.  Observations on Alcaligenes faecalis infection in turkeys.

Authors:  Y M Saif; P D Moorhead; R N Dearth; D J Jackwood
Journal:  Avian Dis       Date:  1980 Jul-Sep       Impact factor: 1.577

Review 7.  In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

8.  Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.

Authors:  P C Appelbaum; J Tamim; G A Pankuch; R C Aber
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

9.  Bordetella bronchicanis (bronchiseptica) infection in man: review and a case report.

Authors:  H K Ghosh; J Tranter
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

10.  Bordetella bronchiseptica bronchitis.

Authors:  C J Papasian; N J Downs; R L Talley; D J Romberger; G R Hodges
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948
  10 in total
  13 in total

1.  Application of 16S rRNA gene sequencing to identify Bordetella hinzii as the causative agent of fatal septicemia.

Authors:  M M Kattar; J F Chavez; A P Limaye; S L Rassoulian-Barrett; S L Yarfitz; L C Carlson; Y Houze; S Swanzy; B L Wood; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Bordetella avium antibiotic resistance, novel enrichment culture, and antigenic characterization.

Authors:  Nathan M Beach; Seth Thompson; Rachel Mutnick; Lisa Brown; Gina Kettig; Robyn Puffenbarger; Stephanie B Stockwell; David Miyamoto; Louise Temple
Journal:  Vet Microbiol       Date:  2012-06-02       Impact factor: 3.293

3.  Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections.

Authors:  Kristina Kadlec; Corinna Kehrenberg; Jürgen Wallmann; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Bordetella bronchiseptica bronchitis in an immunosuppressed patient.

Authors:  J F Meis; A J van Griethuijsen; H L Muytjens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

Review 5.  Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period.

Authors:  G Funke; T Hess; A von Graevenitz; P Vandamme
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Isolation of a Bordetella avium-like organism from a human specimen.

Authors:  C Dorittke; P Vandamme; K H Hinz; E M Schemken-Birk; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

Review 7.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.

Authors:  Sandra Prüller; Ulrike Rensch; Diana Meemken; Heike Kaspar; Peter A Kopp; Günter Klein; Corinna Kehrenberg
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

9.  Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease.

Authors:  Amanda T Harrington; Jaime A Castellanos; Tomasz M Ziedalski; Jill E Clarridge; Brad T Cookson
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

10.  Relapsing peritonitis caused by Bordetella bronchiseptica in continuous ambulatory peritoneal dialysis patient: a case report.

Authors:  Ki-Bum Won; Gyoung-Yim Ha; Joon-Seup Kim; Hyeock-Joo Kang; Woo-Taek Tak; Jeong-Ho Lee
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.